Maria Bjerke

Maria Bjerke is a Researcher in Clinical Biology at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), with affiliation to Universitair Ziekenhuis Brussel (UZ Brussel). Her work focuses on neuroprotection and neuromodulation, with extensive contributions to Alzheimer's disease research and biomarker development. With an h-index of 37 and over 7,202 citations, she has established significant impact in her field through 96 research outputs spanning from 2007 to 2024.

Dr. Bjerke's research interests center on cerebrospinal fluid biomarkers, amyloid pathology, and cognitive dysfunction in neurodegenerative diseases. Her fingerprint analysis reveals strong activity in Alzheimer Disease (90%), Biomarkers (64%), dementia (48%), Dementia (36%), Cognitive Dysfunction (34%), Amyloid (33%), and Intermediate Filaments (20%). She bridges laboratory research with clinical applications to improve diagnosis and monitoring of dementia patients.

Her recent publications demonstrate a sophisticated approach to understanding brain aging, Alzheimer's progression, and potential therapeutic interventions. She employs advanced methodologies including neuroimaging, cerebrospinal fluid analysis, and cutting-edge analytical chemistry techniques. Dr. Bjerke actively contributes to major international conferences on Alzheimer's disease and frontotemporal dementias, maintaining visibility in the global neuroscience community.

She currently participates in the IOF GEAR project (2022-2026), which applies artificial intelligence to neurology, neurosurgery, and psychiatry. This €4 million initiative focuses on Applied Cognition (100%), Machine Learning (95%), Brain Diseases (80%), Psychiatry (62%), and Deep Learning (57%). Dr. Bjerke also serves as research supervisor, having guided at least one Master's student in neurofilament light chain quantification research.